Recombinant multi-species WRN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WRN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the RecQ subfamily of DNA helicase proteins. The encoded nuclear protein is important in the maintenance of genome stability and plays a role in DNA repair, replication, transcription and telomere maintenance. This protein contains a N-terminal 3' to 5' exonuclease domain, an ATP-dependent helicase domain and RQC (RecQ helicase conserved region) domain in its central region, and a C-terminal HRDC (helicase RNase D C-terminal) domain and nuclear localization signal. Defects in this gene are the cause of Werner syndrome, an autosomal recessive disorder characterized by accelerated aging and an elevated risk for certain cancers. [provided by RefSeq, Aug 2017]
The Alternative Names of target: Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN,DNA helicase,RECQ3,RECQL2,RECQL3,RGD1564788,RecQ protein-like 2,RecQ-like type 3,WRN,Werner syndrome protein,Wrn

Target products collectionGo to WRN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T47583-Ag-1/ GM-Tg-hg-T47583-Ag-2 Human WRN protein Human
GM-Tg-rg-T47583-Ag-1/ GM-Tg-rg-T47583-Ag-2 Rat WRN protein Rat
GM-Tg-mg-T47583-Ag-1/ GM-Tg-mg-T47583-Ag-2 Mouse WRN protein Mouse
GM-Tg-cynog-T47583-Ag-1/ GM-Tg-cynog-T47583-Ag-2 Cynomolgus/Rhesus macaque WRN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T47583-Ag-1/ GM-Tg-felg-T47583-Ag-2 Feline WRN protein Feline
GM-Tg-cang-T47583-Ag-1/ GM-Tg-cang-T47583-Ag-2 Canine WRN protein Canine
GM-Tg-bovg-T47583-Ag-1/ GM-Tg-bovg-T47583-Ag-2 Bovine WRN protein Bovine
GM-Tg-equg-T47583-Ag-1/ GM-Tg-equg-T47583-Ag-2 Equine WRN protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T47583-Ag-1/ GM-Tg-hg-T47583-Ag-2; GM-Tg-rg-T47583-Ag-1/ GM-Tg-rg-T47583-Ag-2;
GM-Tg-mg-T47583-Ag-1/ GM-Tg-mg-T47583-Ag-2; GM-Tg-cynog-T47583-Ag-1/ GM-Tg-cynog-T47583-Ag-2;
GM-Tg-felg-T47583-Ag-1/ GM-Tg-felg-T47583-Ag-2; GM-Tg-cang-T47583-Ag-1/ GM-Tg-cang-T47583-Ag-2;
GM-Tg-bovg-T47583-Ag-1/ GM-Tg-bovg-T47583-Ag-2; GM-Tg-equg-T47583-Ag-1/ GM-Tg-equg-T47583-Ag-2
Products Name WRN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name WRN
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WRN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.